Yolanda Owens
Psychiatric/Mental Health · Nashville, TNNPI 1801537048
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,353 and has fallen 92.7% since, to $246 in 2025. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $31.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Neurocrine Biosciences, Inc.$1K
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$706
- Axsome Therapeutics, Inc.$619
- Teva Pharmaceuticals USA, Inc.$418
- plus $2K from 13 others
What the payments were for
- Food & beverage$7,308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $1,615 |
| Neurocrine Biosciences, Inc. | 35 | $1,221 |
| Alkermes, Inc. | 31 | $1,065 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $706 |
| Axsome Therapeutics, Inc. | 15 | $619 |
| Teva Pharmaceuticals USA, Inc. | 9 | $418 |
| Johnson & Johnson | 7 | $380 |
| Otsuka America Pharmaceutical, Inc. | 17 | $351 |
| Vanda Pharmaceuticals Inc. | 7 | $254 |
| Supernus Pharmaceuticals, Inc. | 14 | $174 |
| Idorsia Pharmaceuticals US Inc | 2 | $129 |
| Ironshore Pharmaceuticals Inc. | 6 | $122 |
| Corium, LLC | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $71 |
| Harmony Biosciences LLC | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $23 |
| Tris Pharma Inc | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $14 |
| Indivior Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,308 in reported general payments places this provider in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 11 | $576 |
| Quetiapine Fumarate | 13 | $374 |
| Fluoxetine Hcl | 14 | $266 |
| Buspirone Hcl | 12 | $182 |
| Duloxetine Hcl | 17 | $177 |
| Bupropion XlBupropion Hcl | 20 | $164 |
| Clonazepam | 23 | $86 |
| Trazodone Hcl | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Nashville
- Kristian DambrinoNashville$449K
- Lauren HansenNashville$263K
- Aaron JonesNashville$20K
- Kathleen McCoyNashville$12K
- Preeti SrivastavaNashville$11K
- Kersten WoodleeNashville$10K
- Ariel NewtonNashville$10K
- Robert McKeownNashville$10K
- Debra YorkNashville$9K
- Laura MelaroBolivar$682K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.